A carregar...
The Framingham risk score underestimates the risk of cardiovascular events in the HER2-positive breast cancer population
INTRODUCTION: Patients with breast cancer (bca) who overexpress her2 (the human epidermal growth factor receptor 2) are at risk for cardiotoxicity when treated with anthracycline-based chemotherapy and her2-targeted agents. The Framingham risk score (frs) is a validated tool that stratifies patients...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659158/ https://ncbi.nlm.nih.gov/pubmed/29089804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3684 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|